Drugmaker Lilly cuts revenue forecast as dollar strengthens

(Reuters) - Eli Lilly and Co cut its 2015 revenue forecast, issued earlier this month, as the U.S. drugmaker expects a bigger hit from a stronger dollar. The company had accounted for an expected $500 million negative impact from the stronger dollar in its earlier forecast. Large U.S. healthcare companies such as Johnson & Johnson , Pfizer Inc and Bristol-Myers Squibb Co have in the past weeks issued 2015 earnings forecasts below Wall Street expectations, citing the stronger dollar. ...